Regulatory News

ABSCIENCES (EPA:AB)
13/03/2024 12:58
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
07/03/2024 15:20
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
06/03/2024 20:21
AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
29/02/2024 11:49
AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
26/02/2024 18:32
AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALS
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
28/11/2023 19:22
AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell disease
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
27/11/2023 08:04
AB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning projects under the sixth call for “Hospital-Inuversity Research in health (RHU)”
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
29/09/2023 19:49
AB Science today reports its revenues for the first half of 2023 and provides an update on its activities
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
18/09/2023 18:05
AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
Expand news
Display more news published by ABSCIENCES
ABSCIENCES (EPA:AB)
01/06/2023 18:01
AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037
Expand news
Display more news published by ABSCIENCES

Other stories

03/05/2024 17:09
UK local elections: Labour flips seats it hasn't held in decades - The Associated Press
03/05/2024 17:53
Alfie Lewis: Teenager found guilty of murdering boy, 15, in Leeds - BBC
03/05/2024 17:28
Labour’s Claire Ward elected first mayor of East Midlands - The Guardian
03/05/2024 14:14
Murder arrest after man stabbed to death - Liverpool Echo
03/05/2024 18:41
Critical incident at BRI in Bristol after power outage and fire - BBC.com
03/05/2024 09:54
Trump trial: Hope Hicks, former key Trump aide, called to witness stand - BBC
03/05/2024 19:16
Hainault sword attack: Daniel Anjorin fundraiser hits £100k as police issue update - The Independent
03/05/2024 19:23
Rwanda scheme legal challenge: Charity preparing action - BBC
03/05/2024 18:30
Ukraine-Russia war: Kremlin accuses David Cameron of 'direct escalation' over weapons for Kyiv - The Telegraph
03/05/2024 17:36
Porsche driver dies after car 'tried to swerve pothole' in four-vehicle crash - The Sun
03/05/2024 13:49
Brazil floods: 29 people killed and thousands more displaced - Sky News
03/05/2024 11:20
British man in critical condition after 15 hurt in Turkey bus crash - The Times
03/05/2024 11:00
US confirms Russian forces deployed to same Niger airbase as American troops - The Guardian
03/05/2024 10:43
Turkey halts trade with Israel over 'humanitarian tragedy' in Gaza - BBC
03/05/2024 14:12
Locked and loaded for the April edition of non-farm payrolls - ForexLive
03/05/2024 03:30
Goldman Sachs to scrap cap on bonuses for hundreds of UK staff - The Guardian
03/05/2024 14:07
Port Talbot: Tata Steel redundancy offer callous attack, unions say - BBC
03/05/2024 19:00
Accounting firm used by Trump Media hit with 'massive fraud' charge - The Independent
03/05/2024 09:54
Samsung's customization app Good Lock is finally on the Play Store - Android Central
02/05/2024 03:31
ChatGPT’s chatbot rival Claude to be introduced on iPhone - The Guardian
01/05/2024 10:43
Ghost Of Tsushima gets surprise update you can download now - GAMINGbible
03/05/2024 18:02
'Helldivers 2' PC Players Mad About PSN Account Linking, Arrowhead Responds - Forbes
03/05/2024 18:16
Gavin and Stacey to return for last-ever episode on Christmas Day, BBC confirms - The Guardian
03/05/2024 14:06
What's going on at Manchester's Co-op Live? The arena plagued with problems and postponements - Sky News
03/05/2024 11:42
'I blame myself for Rod Hull's death': Gyles Brandreth reveals heartbreaking story behind fatal accident - LBC
03/05/2024 16:09
Jimmy Carr called out for 'disgusting' behaviour on This Morning - The Independent
03/05/2024 18:16
LIVE COVERAGE: Follow all the action from first practice for the Miami Grand Prix | Formula 1® - Formula 1
03/05/2024 15:21
West Ham close to deal for Julen Lopetegui to take over as manager - The Guardian
03/05/2024 16:48
QIPCO 2000 Guineas preview: David Ord on City Of Troy - Sportinglife.com
03/05/2024 17:26
Jurgen Klopp lets rip at TNT Sports in rant about Liverpool fixtures - The Telegraph
03/05/2024 11:33
China rocket blasts off for far side of Moon - BBC
02/05/2024 17:47
Unravelling life's origin: five key breakthroughs from the past five years - The Conversation
03/05/2024 10:15
Don't Miss: Eta Aquariid Meteor Shower, Red Giant Star Antares, and May Planets - SciTechDaily
03/05/2024 19:30
Homerton Fertility Centre: Licence ban extended after loss of some embryos - BBC
03/05/2024 16:30
'I'm a pharmacist - this red flag sign in your fingers could signal 3 killer conditions' - Express
03/05/2024 06:00
'Red flag' toilet symptom that could mean bladder cancer - Liverpool Echo
03/05/2024 01:44
'Life-changing' sickle cell disease treatment made available on NHS - Sky News
03/05/2024 14:46
Experts say sign in feet and ankles can be red flag for life-threatening condition - The Mirror

©Dissemination technology Webdisclosure.com - copyright 2024 SYMEX ECONOMICS all rights reserved

For any question or partnership, thanks for
     Calling us : +44 203 445 5045
     Sending us a mail : info@regulatorynews.co.uk